Noradrenalin antagonizes effects of serotonin and acetylcholine in the seawater eel intestine

After inhibiting ion and water transport with 10^-6 mol·l^-1 serotonin and 10^-6 mol·l^-1 methacholine, a muscarinic agonist of acetylcholine, 10^-5 mol·l^-1 (±)noradrenaline restored the serosa-negative transepithelial potential difference and short-circuit current in a step-like manner, accompanied by an increase in water absorption across the seawater eel intestine. Such recovery by noradrenalin was not obtained after pretreatment with 10^-7 mol·l^-1 eel atrial natriuretic peptide. This means that the inhibitory mechanisms of serotonin and acetylcholine are different from those of atrial natriuretic peptide. Similarly, 10^-7 mol·l^-1 clonidine and guanabenz (₂-agonists) also reversed the inhibitory action of serotonin and methacholine, but 10^-7 mol·l^-1 phenylephrine (₁-agonists) and 10^-7 mol·l^-1 isoproterenol (-agonist) did not antagonize serotonin and methacholine actions. Further, the enhancement by 10^-5 mol·l^-1 noradrenalin was blocked by 10^-4 mol·l^-1 yohimbine (₂-agonists) and 10^-4 mol·l^-1 prazosin (₁-agonists), but not by 10^-4 mol·l^-1 propranolol (-antagonist). Although relatively high dosage is required to obtain a significant effect, and discrimination between ₁- and ₂- is not successful in the present study, these results suggest that noradrenalin acts on an -type receptor. The -type receptor may exist on the enterocytes, since the effects of noradrenalin are observed even in the presence of 10^-6 mol·l^-1 tetrodotoxin. Interestingly, the tissue resistance also increased in parallel with increase in the short-circuit current after treatment with noradrenalin in the posterior part of the seawater eel intestine.Abbreviations ACh acetylcholine - 5-HT serotonin - eANP eel atrial natriuretic peptide - I _sc short-circuit current - MCh methacholine - NA noradrenalin - PD transepithelial potential difference - R _t tissue resistance - TTX tetrodotoxin - VIP vasoactive intestinal peptide